TopFunds

Medtronic plc

NYSE: MDT

Stock price

94.75 USD

(+0%) TODAY

Medical - Devices
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
2.5
2.9
2.3
3.4
3.5
2.7
3.7
2.8
2.8
3.6
3.7
4.2%
02Free cash flow per share
2.9
4
2.6
4.3
4.5
3.6
4.4
3.4
3.9
4
4.2
3.7%
03Dividends per share
1.5
1.7
1.8
2
2.2
2.3
2.5
2.7
2.8
2.8
2.8
6.5%
04Dividends payout, %
60.5%
59%
80.4%
58.2%
60.4%
86.5%
67.1%
96.2%
99.7%
77%
75.8%
2.3%
PROFIT AND LOSS STATEMENT
05Revenue
28,833
29,710
29,953
30,557
28,913
30,117
31,686
31,227
32,364
33,537
36,364
2.4%
06% Change
-
-
-
-
-
-
-
-
-
-
-
2.4%
07Cost of revenue
(9,142)
(9,294)
(9,067)
(9,155)
(9,424)
(10,483)
(10,145)
(10,719)
(11,216)
(11,632)
(12,721)
3.4%
08Gross profit
19,691
20,416
20,886
21,402
19,489
19,634
21,541
20,508
21,148
21,905
23,643
1.9%
09% Margin
68.3%
68.7%
69.7%
70%
67.4%
65.2%
68%
65.7%
65.3%
65.3%
65%
67.2% A
10Operating expenses
(14,330)
(15,033)
(14,246)
(15,134)
(14,698)
(15,150)
(15,789)
(15,023)
(16,004)
(15,950)
(17,179)
1.8%
11% of Revenue
(49.7)%
(50.6)%
(47.6)%
(49.5)%
(50.8)%
(50.3)%
(49.8)%
(48.1)%
(49.5)%
(47.6)%
(47.2)%
(49.2)% A
12Operating Income
5,361
5,383
6,640
6,268
4,791
4,484
5,752
5,485
5,144
5,955
6,467
1.9%
13Income tax expense
(798)
(578)
(2,580)
(547)
(751)
(265)
(456)
(1,580)
(1,133)
(936)
(1,299)
5%
14Net Income
3,538
4,028
3,104
4,631
4,789
3,606
5,039
3,758
3,676
4,662
4,800
3.1%
15% Margin
12.3%
13.6%
10.4%
15.2%
16.6%
12%
15.9%
12%
11.4%
13.9%
13.2%
13.3% A
16Shares Outstanding
1,426
1,391
1,368
1,358
1,351
1,354
1,351
1,333
1,330
1,290
1,288
(1)%
17EPS Basic
2.5
2.9
2.3
3.4
3.6
2.7
3.8
2.8
2.8
3.6
3.8
4.1%
18EPS Diluted
2.5
2.9
2.3
3.4
3.5
2.7
3.7
2.8
2.8
3.6
3.7
4.2%
19EBITDA
8,542
8,613
9,465
9,300
7,810
7,522
8,777
8,697
8,203
9,218
9,809
1.4%
% Margin
29.6%
29%
31.6%
30.4%
27%
25%
27.7%
27.9%
25.4%
27.5%
27%
28% A
20Net Interest Income (expense)
(955)
(1,094)
(1,146)
(1,444)
(1,092)
(925)
(553)
(636)
(719)
(729)
(715)
(2.9)%
21Net Debt / EBITDA
3.3
3.3
2.3
2.2
2.6
3
2.3
2.6
2.9
2.9
2.7
2.7 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
2,876
4,967
3,669
4,393
4,140
3,593
3,714
1,543
1,284
2,218
1,949
(3.8)%
23Short-term investments
9,758
8,741
7,558
5,455
6,808
7,224
6,859
6,416
6,721
6,747
7,271
(2.9)%
24Accounts receivable
5,562
5,591
5,987
6,222
4,645
5,462
5,551
5,998
6,128
6,515
6,643
1.8%
25Other current assets
1,931
2,236
2,187
2,144
2,209
1,956
2,319
2,425
2,585
2,858
2,973
4.4%
26Inventory
3,473
3,338
3,579
3,753
4,229
4,313
4,616
5,293
5,217
5,476
5,951
5.5%
27Total Current Assets
23,600
24,873
22,980
21,967
22,031
22,548
23,059
21,675
21,935
23,814
24,787
0.5%
Non-Current Assets
28Net property, plant & equipment
4,841
4,361
4,604
4,675
4,828
5,221
5,413
5,569
6,131
6,837
7,417
4.4%
29Long-term investments
-
-
-
-
-
-
-
-
-
-
-
-
30Other non-current assets
71,203
70,623
63,809
63,052
63,830
65,313
62,507
63,705
61,915
61,028
60,823
(1.6)%
31Total Non-Current Assets
76,044
74,984
68,413
67,727
68,658
70,534
67,920
69,274
68,046
67,865
68,240
(1.1)%
Total Assets
99,547
99,816
91,393
89,694
90,689
93,083
90,981
90,948
89,981
91,680
93,028
(0.7)%
LIABILITIES
Current Liabilities
32Accounts payable
1,709
1,555
1,628
1,953
1,996
2,106
2,276
2,662
2,410
2,449
2,644
4.5%
33Short-term debt
1,099
7,525
2,063
838
2,776
11
3,742
20
1,092
2,874
1,788
5%
34Other current liabilities
4,357
5,184
6,393
5,681
5,594
6,392
6,376
6,369
7,287
7,556
7,226
5.2%
35Total Current Liabilities
7,165
14,264
10,084
8,472
10,366
8,509
12,394
9,051
10,789
12,879
11,658
5%
Non-Current Liabilities
36Long-term debt
30,020
25,881
23,705
24,477
22,021
26,378
20,372
24,344
23,932
25,642
26,173
(1.4)%
37Other non-current liabilities
10,534
9,299
6,782
6,533
7,430
6,594
5,493
5,888
4,840
4,903
5,125
(7)%
38Total Non-Current Liabilities
40,554
35,180
30,487
31,010
29,451
32,972
25,865
30,232
28,772
30,545
31,298
(2.6)%
39Total Liabilities
47,719
49,400
40,571
39,482
39,817
41,481
38,259
39,283
39,561
43,424
42,956
(1.1)%
SHAREHOLDERS` EQUITY
40Common stock
-
-
-
-
-
-
-
-
-
-
-
-
41Retained earnings / (deficit)
21,704
23,356
24,379
26,270
28,132
28,594
30,250
30,392
30,403
31,476
32,638
4.2%
42Accumulated other comprehensive income / (loss)
(1,868)
(2,613)
(1,786)
(2,711)
(3,560)
(3,485)
(2,265)
(3,499)
(3,318)
(4,284)
(4,101)
8.2%
43Noncontrolling interests
-
122
102
121
135
174
171
182
206
232
609
-
44Total shareholders' equity
51,828
50,416
50,822
50,212
50,872
51,602
52,722
51,665
50,420
48,256
50,072
(0.3)%
45Total Liabilities and shareholders' Equity
99,547
99,816
91,393
89,694
90,689
93,083
90,981
90,948
89,981
91,680
93,028
(0.7)%
46Total Debt
31,013
33,401
25,763
25,315
24,797
26,389
24,114
24,364
25,024
28,516
27,961
(1)%
47Net Debt
28,137
28,434
22,094
20,922
20,657
22,796
20,400
22,821
23,740
26,298
26,012
(0.8)%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
3,538
4,028
3,104
4,631
4,789
3,606
5,039
3,758
3,676
4,662
4,800
3.1%
49Depreciation & amortization
2,820
2,917
2,644
2,659
2,663
2,702
2,707
2,697
2,647
2,861
2,958
0.5%
50Share-based compensation expense
376
348
344
290
297
344
359
355
393
429
457
2%
51Changes in working capital and other assets
(1,516)
(413)
(1,408)
(573)
(515)
(412)
(759)
(771)
71
(908)
(885)
(5.2)%
52Net cash flows from operating activities
5,218
6,880
4,684
7,007
7,234
6,240
7,346
6,039
6,787
7,044
7,330
3.5%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(1,046)
(1,254)
(1,068)
(1,134)
(1,213)
(1,355)
(1,368)
(1,459)
(1,587)
(1,859)
(1,904)
6.2%
54Purchases of investments / marketable securities
(5,406)
(4,371)
(3,200)
(2,532)
(11,039)
(11,808)
(9,882)
(7,514)
(7,748)
(8,226)
(8,725)
4.9%
55Proceeds from maturities of marketable securities
9,924
5,356
4,227
4,683
9,574
11,345
9,692
7,343
7,441
8,495
8,105
(2)%
56Other investing activities
(1,227)
(1,302)
5,899
(1,791)
(525)
(1,048)
(101)
(1,863)
(472)
(347)
(410)
(10.4)%
57Net cash flows from investing activities
2,245
(1,571)
5,858
(774)
(3,203)
(2,866)
(1,659)
(3,493)
(2,366)
(1,937)
(2,934)
-
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
(2,339)
(3,116)
(1,768)
(1,885)
(664)
(178)
(2,115)
(337)
(1,854)
(2,727)
(519)
(14)%
59Dividends paid, net
(2,139)
(2,376)
(2,494)
(2,693)
(2,894)
(3,120)
(3,383)
(3,616)
(3,666)
(3,589)
(3,639)
5.5%
60Debt issuance (repayments), net
(5,125)
2,183
(7,598)
(867)
(559)
(570)
(1)
(598)
1,073
2,139
(1,174)
(13.7)%
61Other financing activities
60
26
(94)
14
(81)
(268)
163
(409)
(3)
(184)
581
25.5%
62Net cash flows from financing activities
(9,543)
(3,283)
(11,954)
(5,431)
(4,198)
(4,136)
(5,336)
(4,960)
(4,450)
(4,361)
(4,751)
(6.7)%
63Increase (decrease) in cash and cash equivalents
(1,967)
2,091
(1,298)
724
(253)
(547)
121
(2,171)
(259)
934
(269)
(18)%
64Cash and equivalents, ending balance
2,876
4,967
3,669
4,393
4,140
3,593
3,714
1,543
1,284
2,218
1,949
(3.8)%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
4,172
5,626
3,616
5,873
6,021
4,885
5,978
4,580
5,200
5,185
5,426
2.7%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2026202520242023202220212020201920182017

Medtronic plc (MDT) financial statements and performance

Explore Medtronic plc (MDT) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.